Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM.

Marchegiani G, Andrianello S, Malleo G, De Gregorio L, Scarpa A, Mino-Kenudson M, Maggino L, Ferrone CR, Lillemoe KD, Bassi C, Castillo CF, Salvia R.

Ann Surg. 2016 Jun 17. [Epub ahead of print]

PMID:
27322188
2.

"Idealized" vs. "True" learning curves: the case of laparoscopic liver resection.

Villani V, Bohnen JD, Torabi R, Sabbatino F, Chang DC, Ferrone CR.

HPB (Oxford). 2016 Jun;18(6):504-9. doi: 10.1016/j.hpb.2016.03.610. Epub 2016 Apr 26.

3.

Obesity-induced inflammation and desmoplasia promote pancreatic cancer progression and resistance to chemotherapy.

Incio J, Liu H, Suboj P, Chin SM, Chen IX, Pinter M, Ng MR, Nia HT, Grahovac J, Kao S, Babykutty S, Huang Y, Jung K, Rahbari NN, Han X, Chauhan VP, Martin JD, Kahn J, Huang P, Desphande V, Michaelson J, Michelakos TP, Ferrone CR, Soares R, Boucher Y, Fukumura D, Jain RK.

Cancer Discov. 2016 May 31. pii: CD-15-1177. [Epub ahead of print]

PMID:
27246539
4.

Isocitrate Dehydrogenase Mutations Confer Dasatinib Hypersensitivity and SRC Dependence in Intrahepatic Cholangiocarcinoma.

Saha SK, Gordan JD, Kleinstiver BP, Vu P, Najem MS, Yeo JC, Shi L, Kato Y, Levin RS, Webber JT, Damon LJ, Egan RK, Greninger P, McDermott U, Garnett MJ, Jenkins RL, Rieger-Christ KM, Sullivan TB, Hezel AF, Liss AS, Mizukami Y, Goyal L, Ferrone CR, Zhu AX, Joung JK, Shokat KM, Benes CH, Bardeesy N.

Cancer Discov. 2016 May 26. [Epub ahead of print]

PMID:
27231123
5.

Treatment of Locally Advanced Pancreatic Ductal Adenocarcinoma.

Loehrer AP, Ferrone CR.

Dig Surg. 2016;33(4):343-50. doi: 10.1159/000445020. Epub 2016 May 25.

6.

Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients with Pancreatic Adenocarcinoma.

Allen PJ, Kuk D, Castillo CF, Basturk O, Wolfgang CL, Cameron JL, Lillemoe KD, Ferrone CR, Morales-Oyarvide V, He J, Weiss MJ, Hruban RH, Gönen M, Klimstra DS, Mino-Kenudson M.

Ann Surg. 2016 May 9. [Epub ahead of print]

PMID:
27163957
7.

A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.

Indolfi L, Ligorio M, Ting DT, Xega K, Tzafriri AR, Bersani F, Aceto N, Thapar V, Fuchs BC, Deshpande V, Baker AB, Ferrone CR, Haber DA, Langer R, Clark JW, Edelman ER.

Biomaterials. 2016 Jul;93:71-82. doi: 10.1016/j.biomaterials.2016.03.044. Epub 2016 Mar 31.

PMID:
27082874
8.

Phosphorylated Histone H3 (PHH3) Is a Superior Proliferation Marker for Prognosis of Pancreatic Neuroendocrine Tumors.

Villani V, Mahadevan KK, Ligorio M, Fernández-Del Castillo C, Ting DT, Sabbatino F, Zhang I, Vangel M, Ferrone S, Warshaw AL, Lillemoe KD, Wargo J, Deshpande V, Ferrone CR.

Ann Surg Oncol. 2016 Mar 28. [Epub ahead of print]

PMID:
27020585
9.

Spectrum and Classification of Cystic Neoplasms of the Pancreas.

Greer JB, Ferrone CR.

Surg Oncol Clin N Am. 2016 Apr;25(2):339-50. doi: 10.1016/j.soc.2015.11.002. Review.

PMID:
27013368
10.

Intra-pancreatic Distal Bile Duct Carcinoma is Morphologically, Genetically, and Clinically Distinct from Pancreatic Ductal Adenocarcinoma.

Deshpande V, Konstantinidis IT, Castillo CF, Hezel AF, Haigis KM, Ting DT, Bardeesy N, Goyal L, Zhu AX, Warshaw AL, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2016 May;20(5):953-9. doi: 10.1007/s11605-016-3108-0. Epub 2016 Mar 8.

PMID:
26956004
11.

High-fat diet enhances stemness and tumorigenicity of intestinal progenitors.

Beyaz S, Mana MD, Roper J, Kedrin D, Saadatpour A, Hong SJ, Bauer-Rowe KE, Xifaras ME, Akkad A, Arias E, Pinello L, Katz Y, Shinagare S, Abu-Remaileh M, Mihaylova MM, Lamming DW, Dogum R, Guo G, Bell GW, Selig M, Nielsen GP, Gupta N, Ferrone CR, Deshpande V, Yuan GC, Orkin SH, Sabatini DM, Yilmaz ÖH.

Nature. 2016 Mar 3;531(7592):53-8. doi: 10.1038/nature17173.

PMID:
26935695
12.

Surgical management of intrahepatic cholangiocarcinoma in the modern era: advances and challenges.

Konstantinidis IT, Arkadopoulos N, Ferrone CR.

Chin Clin Oncol. 2016 Feb;5(1):9. doi: 10.3978/j.issn.2304-3865.2016.02.06.

13.

Antitumor Activity of BRAF Inhibitor and IFNα Combination in BRAF-Mutant Melanoma.

Sabbatino F, Wang Y, Scognamiglio G, Favoino E, Feldman SA, Villani V, Flaherty KT, Nota S, Giannarelli D, Simeone E, Anniciello AM, Palmieri G, Pepe S, Botti G, Ascierto PA, Ferrone CR, Ferrone S.

J Natl Cancer Inst. 2016 Feb 5;108(7). pii: djv435. doi: 10.1093/jnci/djv435. Print 2016 Jul.

PMID:
26851802
14.

Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: Is This Really a Short Learning Curve?

Fong ZV, Chang DC, Ferrone CR, Lillemoe KD, Fernandez Del Castillo C.

J Am Coll Surg. 2016 Feb;222(2):209. doi: 10.1016/j.jamcollsurg.2015.11.004. No abstract available.

PMID:
26809387
15.

Preoperative biliary drainage does not increase major complications in pancreaticoduodenectomy: a large single center experience from the Massachusetts General Hospital.

Sahora K, Morales-Oyarvide V, Ferrone C, Fong ZV, Warshaw AL, Lillemoe KD, Fernández-Del Castillo C.

J Hepatobiliary Pancreat Sci. 2016 Mar;23(3):181-7. doi: 10.1002/jhbp.322. Epub 2016 Feb 23.

PMID:
26768943
16.

Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current State of the Art and Ongoing Controversies.

Fong ZV, Ferrone CR, Lillemoe KD, Fernández-Del Castillo C.

Ann Surg. 2016 May;263(5):908-17. doi: 10.1097/SLA.0000000000001567.

PMID:
26727096
17.

Discordance Between Perioperative Antibiotic Prophylaxis and Wound Infection Cultures in Patients Undergoing Pancreaticoduodenectomy.

Fong ZV, McMillan MT, Marchegiani G, Sahora K, Malleo G, De Pastena M, Loehrer AP, Lee GC, Ferrone CR, Chang DC, Hutter MM, Drebin JA, Bassi C, Lillemoe KD, Vollmer CM, Fernández-Del Castillo C.

JAMA Surg. 2016 May 1;151(5):432-9. doi: 10.1001/jamasurg.2015.4510.

PMID:
26720272
18.

Operative Versus Nonoperative Management of Nonfunctioning Pancreatic Neuroendocrine Tumors.

Zhang IY, Zhao J, Fernandez-Del Castillo C, Braun Y, Razmdjou S, Warshaw AL, Lillemoe KD, Ferrone CR.

J Gastrointest Surg. 2016 Feb;20(2):277-83. doi: 10.1007/s11605-015-3043-5. Epub 2015 Dec 21.

PMID:
26691146
19.

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Hong TS, Wo JY, Yeap BY, Ben-Josef E, McDonnell EI, Blaszkowsky LS, Kwak EL, Allen JN, Clark JW, Goyal L, Murphy JE, Javle MM, Wolfgang JA, Drapek LC, Arellano RS, Mamon HJ, Mullen JT, Yoon SS, Tanabe KK, Ferrone CR, Ryan DP, DeLaney TF, Crane CH, Zhu AX.

J Clin Oncol. 2016 Feb 10;34(5):460-8. doi: 10.1200/JCO.2015.64.2710. Epub 2015 Dec 14.

PMID:
26668346
20.

Health Insurance Expansion and Treatment of Pancreatic Cancer: Does Increased Access Lead to Improved Care?

Loehrer AP, Chang DC, Hutter MM, Song Z, Lillemoe KD, Warshaw AL, Ferrone CR.

J Am Coll Surg. 2015 Dec;221(6):1015-22. doi: 10.1016/j.jamcollsurg.2015.09.010. Epub 2015 Oct 9.

PMID:
26611798
Items per page

Supplemental Content

Loading ...
Write to the Help Desk